Predict your next investment

Corporation
CONSUMER PRODUCTS & SERVICES
philips.com

See what CB Insights has to offer

Investments

55

Portfolio Exits

29

Partners & Customers

10

Service Providers

2

About Philips

Philips (NYSE:PHG) is a diversified technology company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle, and Lighting. The company provides cardiac care, acute care and home healthcare, energy efficient lighting solutions, and new lighting applications, as well as male shaving and grooming and oral healthcare.

Philips Headquarter Location

Boschdijk 525

Amsterdam, 5621 JG,

Netherlands

+31 20 597 7777

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Philips

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Philips in 5 Expert Collections, including Digital Health.

D

Digital Health

410 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)

H

Health IT

2,853 items

C

Conference Exhibitors

6,062 items

Companies that will be exhibiting at CES 2018

M

Medical Devices

4,722 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

H

Health Monitoring & Diagnostics

377 items

Companies developing technology to facilitate point-of-care (POC) diagnostic imaging. Excludes intraoperative imaging. Companies tagged as #PointOfCareImaging

Philips Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Philips Rank

Latest Philips News

New release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency

May 16, 2022

May 16, 2022 EchoNavigator 4.0 empowers heart teams with greater control of live fusion imaging plus new anatomical modeling and transseptal puncture guidance during minimally-invasive procedures Seamless integration and communication between Philips Ultrasound System - EPIQ CVxi - and Philips Image Guided Therapy System - Azurion - supports efficient fusion-imaging workflow for minimally-invasive treatment of structural heart disease Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced at EuroPCR (17 - 20 May 2022, Paris, France) the international launch of EchoNavigator 4.0 [1], the new release of its advanced image-guided therapy solution for the treatment of structural heart disease. EchoNavigator 4.0 gives users of Philips’ EPIQ CVXi interventional cardiology ultrasound system greater control of live fusion-imaging on the company’s Image Guided Therapy System - Azurion - platform. By integrating real-time transesophageal echocardiography (TEE), which places the ultrasound transducer close to the heart, and X-ray fluoroscopy, EchoNavigator 4.0 helps interventional teams to decide, guide, treat, and confirm complex structural heart disease therapy, such as heart valve repair or replacement. The solution also includes extended anatomical intelligence models, transseptal puncture guidance to help access the left atrium and mitral valve from the right atrium, and new 3D live image fusion capabilities, including Philips’ TrueVue photo-realistic rendering and GlassVue volumetric imaging modes. It also features automatic selection of an appropriate set of multiplanar reconstruction planes (sections taken from the 3D echo heart model), with presets for common views of the aortic and mitral valves and left atrial appendage. “The latest EchoNavigator release gives us unique peri-interventional possibilities by offering a comprehensive set of automated views based on advanced 3D heart models in combination with live fusion imaging,” said Dr. Patric Biaggi, Head of Cardiac Imaging at Heart Clinic Hirslanden in Zurich, Switzerland. “This allows us to treat our patients with greater confidence and precision during every stage of the procedure.” Largely due to lifestyle choices and the aging population, structural heart disease is now commonplace in older individuals. In the USA, for example, as many as 1 in 10 people over the age of 75-years are affected by a condition known as mitral regurgitation [2], which means the mitral valve in their heart does not close properly, adversely affecting the amount of oxygenated blood that can be pumped round their body. Worldwide, around 156 million people are estimated to suffer from the condition [3]. Fortunately, in many cases treating structural heart disease can now be performed via image-guided, minimally-invasive, catheter-based procedures that impose far less trauma than open-heart surgery. Improved communication and teamwork Philips EchoNavigator helps improve communication and teamwork between echocardiographers and interventionists during image-guided therapy by automatically fusing together echocardiography ultrasound and X-ray images, while also enhancing understanding of the relationship between X-ray and ultrasound in an intuitive way that helps interventional teams to complete procedures with greater safety, confidence, and clarity. “Cardiology teams across the world are facing increasing numbers of complex structural heart disease cases and are seeking new ways to deliver effective high-quality care despite staffing shortages,” said Karim Boussebaa, General Manager of Image Guided Therapy Systems at Philips. “By helping echocardiographers and interventionists to work together in even more highly coordinated ways, this new release of EchoNavigator is an important step forward in boosting patient throughput, making more efficient use of time and resources, and achieving positive cardiovascular care outcomes.” Greater control for echocardiographers EchoNavigator 4.0 puts greater control of imaging in the hands of the echocardiographer via the EPIQ ultrasound platform’s touch screen, including the ability to fuse and annotate echocardiography and X-ray fluoroscopy images. Anatomical features can be identified either manually or automatically, with anatomical markers and annotations applied to one modality automatically transposed to the other. Live fusion images, markers, and annotations are immediately visible to interventional cardiologists via the Azurion platform’s FlexVision Pro monitor to help guide catheterization and therapy device deployment. Extended automatic modeling and transseptal puncture guidance Additional context and guidance are provided by EchoNavigator’s automated 3D anatomical modeling capabilities. These include models for the mitral valve and its leaflets, and transseptal area models to help identify the optimum zone in the wall separating the right and left atrium where the septum can be punctured to catheterize the left atrium and mitral valve. These 3D modeling capabilities also allow EchoNavigator 4.0 to automatically select an optimal set of multiplanar reconstruction planes, with presets for optimally viewing the aortic and mitral valves and left atrial appendage. Enhanced fusion imaging with Cardiac TrueVue and TrueVue Glass rendering EchoNavigator 4.0’s fusion imaging capabilities have been further enhanced by the ability to fuse live X-ray fluoroscopy images with live TrueVue and TrueVue Glass rendered echocardiography images to more easily visualize positioning and device-tissue interactions. Philips TrueVue 3D echo rendering improves visualization of anatomical structures and devices, while TrueVue Glass with Color allows interventionists to view the location of regurgitant blood flow across a heart valve. With its long history of leadership in cardiology innovation, informed by continuous collaboration with leading clinical partners, Philips is uniquely positioned to deliver integrated solutions that span the care pathway to help solve cardiology’s daily challenges and provide better heart care with greater efficiency . [1] Philips EchoNavigator 4.0 is not yet available in all markets, e.g not available in USA or China. [2] Lloyd-Jones D, Adams RJ, et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association https://pubmed.ncbi.nlm.nih.gov/20019324/ . [3] Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391(10124):960-969. doi:10.1016/S0140-6736(18)30473-2 https://pubmed.ncbi.nlm.nih.gov/29536860/ . For further information, please contact: Joost Maltha  About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter . Attachment

Philips Investments

55 Investments

Philips has made 55 investments. Their latest investment was in B-SOFT as part of their Corporate Minority - P2P - II on May 5, 2022.

CBI Logo

Philips Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/13/2022

Corporate Minority - P2P - II

B-SOFT

$180M

Yes

1

2/23/2022

Series A

CVAid Medical

$4M

Yes

5

8/24/2021

Series B

DiA Imaging Analysis

$14M

Yes

5

8/20/2021

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

8/2/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/13/2022

2/23/2022

8/24/2021

8/20/2021

8/2/2021

Round

Corporate Minority - P2P - II

Series A

Series B

Series A - III

Series C

Company

B-SOFT

CVAid Medical

DiA Imaging Analysis

Subscribe to see more

Subscribe to see more

Amount

$180M

$4M

$14M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

5

5

10

10

Philips Portfolio Exits

29 Portfolio Exits

Philips has 29 portfolio exits. Their latest portfolio exit was ALung Technologies on May 05, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/5/2022

Acquired

2

7/6/2021

Divestiture

1

5/5/2021

Divestiture

Philips Lifeline

3

5/5/2021

Divestiture

Subscribe to see more

Subscribe to see more

10

5/5/2021

Divestiture

Subscribe to see more

Subscribe to see more

10

Date

5/5/2022

7/6/2021

5/5/2021

5/5/2021

5/5/2021

Exit

Acquired

Divestiture

Divestiture

Divestiture

Divestiture

Companies

Philips Lifeline

Subscribe to see more

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

1

3

10

10

Philips Acquisitions

44 Acquisitions

Philips acquired 44 companies. Their latest acquisition was Vesper Medical on December 14, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/14/2021

Series B

$99M

$52.46M

Acquired

5

11/8/2021

Series A

$99M

$21.4M

Acquired

4

1/19/2021

Growth Equity

$99M

Acquired - II

23

12/18/2020

Other Venture Capital

Subscribe to see more

$99M

$99M

Subscribe to see more

10

8/27/2020

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

12/14/2021

11/8/2021

1/19/2021

12/18/2020

8/27/2020

Investment Stage

Series B

Series A

Growth Equity

Other Venture Capital

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$52.46M

$21.4M

$99M

$99M

Note

Acquired

Acquired

Acquired - II

Subscribe to see more

Subscribe to see more

Sources

5

4

23

10

10

Philips Partners & Customers

10 Partners and customers

Philips has 10 strategic partners and customers. Philips recently partnered with Prisma Health on April 4, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

4/28/2022

Partner

United States

Royal Philips and Prisma Health Enter Multi-Year Agreement

Royal Philips , a leader in health technology , and Prisma Health , South Carolina 's largest non-profit healthcare system , have entered into a multi-year agreement to help the health system achieve enterprise interoperability , standardize patient monitoring , and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance .

2

4/28/2022

Partner

United States

Philips and Prisma Health sign multi-year, long-term strategic partnership to innovate healthcare across the enterprise and unlock the power of patient data

Amsterdam , the Netherlands and South Carolina , USA -- Royal Philips , a global leader in health technology , and Prisma Health , South Carolina 's largest non-profit healthcare system , today announced they have entered into a multi-year agreement to help the health system achieve enterprise interoperability , standardize patient monitoring , and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance .

3

4/27/2022

Partner

United States

ClearPoint Neuro Expands Software License and Research Agreement with Philips to Power Expansion of the ClearPoint Platform into the Operating Room

ClearPoint Neuro , Inc. is partnered with approximately 40 biologics/pharmaceutical companies and academic centers , providing solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide .

1

4/12/2022

Partner

Subscribe to see more

Subscribe to see more

10

3/25/2022

Licensor

United States

Subscribe to see more

Subscribe to see more

10

Date

4/28/2022

4/28/2022

4/27/2022

4/12/2022

3/25/2022

Type

Partner

Partner

Partner

Partner

Licensor

Business Partner

Country

United States

United States

United States

United States

News Snippet

Royal Philips and Prisma Health Enter Multi-Year Agreement

Royal Philips , a leader in health technology , and Prisma Health , South Carolina 's largest non-profit healthcare system , have entered into a multi-year agreement to help the health system achieve enterprise interoperability , standardize patient monitoring , and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance .

Philips and Prisma Health sign multi-year, long-term strategic partnership to innovate healthcare across the enterprise and unlock the power of patient data

Amsterdam , the Netherlands and South Carolina , USA -- Royal Philips , a global leader in health technology , and Prisma Health , South Carolina 's largest non-profit healthcare system , today announced they have entered into a multi-year agreement to help the health system achieve enterprise interoperability , standardize patient monitoring , and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance .

ClearPoint Neuro Expands Software License and Research Agreement with Philips to Power Expansion of the ClearPoint Platform into the Operating Room

ClearPoint Neuro , Inc. is partnered with approximately 40 biologics/pharmaceutical companies and academic centers , providing solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

3

1

10

10

Philips Service Providers

2 Service Providers

Philips has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

XMS Capital Partners

Acquired Unit

Investment Bank

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

XMS Capital Partners

Subscribe to see more

Associated Rounds

Acquired Unit

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Partnership data by VentureSource

Philips Team

174 Team Members

Philips has 174 team members, including current Chief Executive Officer, Neil Mesher.

Name

Work History

Title

Status

Neil Mesher

Chief Executive Officer

Current

Matthew East

Chief Financial Officer

Current

Joseph Frassica

Chief Medical Officer

Current

Chip Truwit MD FACR

Chief Medical Officer

Current

John Payne

Senior Vice President

Current

Name

Neil Mesher

Matthew East

Joseph Frassica

Chip Truwit MD FACR

John Payne

Work History

Title

Chief Executive Officer

Chief Financial Officer

Chief Medical Officer

Chief Medical Officer

Senior Vice President

Status

Current

Current

Current

Current

Current

You May Also Like

P
Paige

Paige delivers AI-powered digital diagnostics and biomarkers for pathologists, oncologists, and the R&D community worldwide, while also working closely with biopharma companies to create custom diagnostic solutions and drug development technologies to improve patient care. The firm's target customers include pathologists, hospital leads/chairs as well as life sciences research and translational teams.

Sectra Logo
Sectra

Sectra (STO: SECTB) develops and sells IT systems and services for radiology and other image-intensive departments, orthopaedics and rheumatology.

1
12 SIGMA

12 SIGMA is a biotechnology company that integrates artificial intelligence and deep learning into modern medical image diagnosis and medical data analysis. 12SIGMA is based in Beijing and San Diego.

Proscia Logo
Proscia

Proscia is a software company focused on transforming cancer research and diagnosis. With the company's Concentriq digital pathology platform and pipeline of AI algorithms, laboratories are leveraging new kinds of data to improve patient outcomes and accelerate discoveries.

Ligence Logo
Ligence

Ligence develops an artificial intelligence-powered automated heart ultrasound analysis system.

mediaire Logo
mediaire

mediaire offers (neuro)radiologists a detailed brain volumetry and lesion report for each patient by an automated, AI-based MRI analysis within just five minutes locally in their center. The radiologist can therefore talk through the MR report within the same patient appointment. Its first product family with mdbrain & mdspine is already certified as a medical device in Europe according to DIN EN ISO 13485:2016.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.